Association Between Use of Renin-Angiotensin System Antagonists and Mortality in Patients With Heart Failure and Preserved Ejection Fraction

医学 心力衰竭 射血分数 内科学 射血分数保留的心力衰竭 倾向得分匹配 心脏病学 队列
作者
Lars H. Lund,Lina Benson,Ulf Dahlström,Magnus Edner
出处
期刊:JAMA [American Medical Association]
卷期号:308 (20): 2108-2108 被引量:166
标识
DOI:10.1001/jama.2012.14785
摘要

Context

Heart failure with preserved ejection fraction (HFPEF) may be as common and as lethal as heart failure with reduced ejection fraction (HFREF). Three randomized trials of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers (ie, renin-angiotensin system [RAS] antagonists) did not reach primary end points but may have had selection bias or been underpowered.

Objective

To test the hypothesis that use of RAS antagonists is associated with reduced all-cause mortality in an unselected population with HFPEF.

Design, Setting, and Patients

Prospective study using the Swedish Heart Failure Registry of 41 791 unique patients registered from 64 hospitals and 84 outpatient clinics between 2000 and 2011. Of these, 16 216 patients with HFPEF (ejection fraction ≥40%; mean [SD] age, 75 [11] years; 46% women) were either treated (n = 12 543) or not treated (n = 3673) with RAS antagonists. Propensity scores for RAS antagonist use were derived from 43 variables. The association between use of RAS antagonists and all-cause mortality was assessed in a cohort matched 1:1 based on age and propensity score and in the overall cohort with adjustment for propensity score as a continuous covariate. To assess consistency, separate age and propensity score–matched analyses were performed according to RAS antagonist dose in patients with HFPEF and in 20 111 patients with HFREF (ejection fraction <40%) in the same registry.

Main Outcome Measure

All-cause mortality.

Results

In the matched HFPEF cohort, 1-year survival was 77% (95% CI, 75%-78%) for treated patients vs 72% (95% CI, 70%-73%) for untreated patients, with a hazard ratio (HR) of 0.91 (95% CI, 0.85-0.98; P = .008). In the overall HFPEF cohort, crude 1-year survival was 86% (95% CI, 86%-87%) for treated patients vs 69% (95% CI, 68%-71%) for untreated patients, with a propensity score–adjusted HR of 0.90 (95% CI, 0.85-0.96; P = .001). In the HFPEF dose analysis, the HR was 0.85 (95% CI, 0.78-0.83) for 50% or greater of target dose vs no treatment (P < .001) and 0.94 (95% CI, 0.87-1.02) for less than 50% of target dose vs no treatment (P = .14). In the age and propensity score–matched HFREF analysis, the HR was 0.80 (95% CI, 0.74-0.86; P < .001).

Conclusion

Among patients with heart failure and preserved ejection fraction, the use of RAS antagonists was associated with lower all-cause mortality.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
qss完成签到,获得积分10
刚刚
华仔的应助被L劉采纳,获得10
5秒前
汪洋慧完成签到 ,获得积分10
10秒前
丘比特的应助被魁梧的钧采纳,获得10
10秒前
丽丽完成签到 ,获得积分10
13秒前
七QI完成签到 ,获得积分10
14秒前
朴实夏寒完成签到,获得积分10
14秒前
阮文名完成签到,获得积分10
15秒前
好风起完成签到 ,获得积分10
16秒前
asdfqaz完成签到,获得积分10
18秒前
周舒鱼完成签到 ,获得积分10
18秒前
19秒前
HAPPY完成签到,获得积分10
20秒前
稳重萃发布了新的文献求助10
23秒前
molihuakai的应助被魁梧的钧采纳,获得10
24秒前
Alex完成签到,获得积分10
25秒前
heart完成签到,获得积分10
26秒前
南枝焙雪完成签到 ,获得积分10
27秒前
Banana完成签到,获得积分10
28秒前
负责的紫安完成签到 ,获得积分10
29秒前
liuchuanfa34完成签到,获得积分10
32秒前
zxy的应助被科研通管家采纳,获得10
34秒前
无极微光的应助被科研通管家采纳,获得20
34秒前
zxy的应助被科研通管家采纳,获得10
34秒前
qinyaopanda的应助被科研通管家采纳,获得10
34秒前
zxy的应助被科研通管家采纳,获得10
35秒前
zxy的应助被科研通管家采纳,获得10
35秒前
群青完成签到 ,获得积分10
38秒前
二碘化钾完成签到 ,获得积分10
39秒前
Ray完成签到,获得积分10
39秒前
南枝焙雪完成签到 ,获得积分10
45秒前
科研通AI65的应助被怡然小白菜采纳,获得10
45秒前
程转完成签到 ,获得积分10
46秒前
炸鲜奶完成签到,获得积分10
51秒前
勤劳觅山完成签到,获得积分10
54秒前
zhh完成签到,获得积分10
58秒前
鸡蛋酱完成签到 ,获得积分10
1分钟前
小菜鸟一碰就碎完成签到 ,获得积分10
1分钟前
科研小白009完成签到 ,获得积分10
1分钟前
原点完成签到,获得积分10
1分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8185520
求助须知:如何正确求助?哪些是违规求助? 9574262
关于积分的说明 21834654
捐赠科研通 7783176
什么是DOI,文献DOI怎么找? 3434577
关于科研通互助平台的介绍 2558951
邀请新用户注册赠送积分活动 2481357